APLM on Nasdaq
Apollomics Inc.
$21.10 down 0.67 (3.08%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
Financial statements
No quarterly figures reported.
Every line of the income statement in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $8.5M | ||
| Other income | $494.0K | $1.5M | $1.2M |
| Foreign exchange (losses) gains | -$141.0K | $145.0K | $1.2M |
| Fair value change of financial assets at FVTPL | $198.0K | $821.0K | |
| Fair value change of financial liabilities at FVTPL | -$22.0K | $222.0K | $1.6M |
| Fair value change of convertible preferred shares | $0 | $0 | -$76.4M |
| Research and development expenses | -$5.5M | -$24.6M | -$34.2M |
| Administrative expenses | -$12.4M | -$17.8M | -$20.6M |
| Impairment of intangible assets | -$1.7M | -$13.0M | $0 |
| Finance costs | -$65.0K | -$179.0K | -$150.0K |
| Other expense | -$12.0K | -$140.0K | -$46.0M |
| Loss before taxation | -$10.9M | -$53.6M | -$172.6M |
| Income tax expenses | -$3.0K | -$259.0K | -$10.0K |
| Loss and total comprehensive loss for the period, net of taxation, attributable to owners of the Company | -$10.9M | -$53.9M | -$172.6M |
| Basic loss per common share (US$) | -$7.57 | -$52.80 | -$231.99 |
| Diluted loss per common share (US$) | -$7.57 | -$52.80 | -$231.99 |
No quarterly figures reported.
Every line of the balance sheet in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Plant and equipment, net | $3.0K | $92.0K | |
| Right-of-use assets | $577.0K | $927.0K | |
| Intangible assets, net | $0 | $1.7M | $14.8M |
| Rental deposits | $83.0K | $75.0K | |
| Total non-current assets | $663.0K | $2.8M | |
| Deposits, prepayments and deferred expenses | $470.0K | $501.0K | |
| Accounts receivable | $2.3M | $0 | |
| Cash and cash equivalents | $3.3M | $9.8M | $32.1M |
| Total current assets | $6.1M | $10.3M | |
| Total assets | $6.7M | $13.1M | |
| Other payables and accruals | $6.1M | $7.2M | |
| Lease liabilities, current portion | $209.0K | $233.0K | |
| Total current liabilities | $6.3M | $7.4M | |
| Net current (liabilities) assets | -$275.0K | $2.9M | |
| Total assets less current liabilities | $388.0K | $5.7M | |
| Lease liabilities, non-current portion | $434.0K | $733.0K | |
| "Warrant liabilities at fair value through profit and loss (""FVTPL"")" | $124.0K | $102.0K | |
| Other non-current liabilities | $3.0M | $0 | |
| Total non-current liabilities | $3.6M | $835.0K | |
| Net (liabilities) assets | -$3.2M | $4.9M | |
| Share capital | $21.0K | $11.0K | |
| Share premium | $670.4M | $666.5M | |
| Reserves | $38.2M | $39.1M | |
| Accumulated deficits | -$711.8M | -$700.8M | |
| Total (deficit) equity | -$3.2M | $4.9M | $41.2M |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Loss before taxation | -$10.9M | -$53.6M | -$172.6M |
| Interest income | -$152.0K | -$198.0K | -$821.0K |
| Depreciation of plant and equipment | $26.0K | $52.0K | $83.0K |
| Depreciation of right-of-use assets | $209.0K | $289.0K | $566.0K |
| Amortization of intangible assets | $20.0K | $20.0K | $20.0K |
| Impairment loss of intangible assets | $1.7M | $13.0M | |
| Loss on disposal of fixed assets | $15.0K | $18.0K | $188.0K |
| Realized foreign currency gains (losses) | -$21.0K | ||
| Fair value change of financial liabilities at FVTPL | $22.0K | -$222.0K | -$1.6M |
| Fair value change of preferred shares | $76.4M | ||
| IFRS 2 listing expense | $45.5M | ||
| Loss on lease termination | $7.0K | ||
| Portion of PIPE issuance costs allocated to PIPE warrants | $38.0K | ||
| Finance costs | $65.0K | $193.0K | $122.0K |
| Share-based payment expenses | -$979.0K | $10.9M | $12.7M |
| Unrealized foreign currency loss | -$258.0K | ||
| Operating cash flows before movements in working capital | -$10.0M | -$29.5M | -$39.6M |
| (Increase) decrease in deposits, prepayments and deferred expenses | -$2.3M | $1.6M | -$932.0K |
| Increase (decrease) in other payables and accruals | $1.9M | -$571.0K | -$2.6M |
| NET CASH USED IN OPERATIONS | -$10.4M | -$28.5M | -$43.2M |
| Taxation paid | -$3.0K | -$259.0K | -$10.0K |
| NET CASH USED IN OPERATING ACTIVITIES | -$10.4M | -$28.7M | -$43.2M |
| Interest received | $152.0K | $198.0K | $821.0K |
| Proceeds from redemption of long term time deposits with original maturity over three months | $4.3M | ||
| Proceeds from redemption of time deposits with original maturity over three months | $2.9M | ||
| Purchase of plant and equipment | -$24.0K | -$6.0K | |
| Proceeds from disposal of fixed assets | $48.0K | $4.0K | $58.0K |
| Proceeds from disposal of financial asset at FVTPL | $5.8M | $13.3M | |
| Payment for rental deposits | $18.0K | ||
| Refund of rental deposits | $44.0K | $5.0K | |
| NET CASH PROVIDED BY INVESTING ACTIVITIES | $218.0K | $6.0M | $21.4M |
| Proceeds from PIPE Financing and Business Combination, net of transaction costs | $3.9M | $5.0M | $20.2M |
| Payment of deferred underwriting fees | -$2.8M | ||
| Repayment of bank loans | -$4.9M | ||
| Proceeds from bank loans | $702.0K | $4.2M | |
| Proceeds from issue of shares upon exercise of share options | $7.0K | $85.0K | |
| Interest expense | -$65.0K | -$193.0K | -$122.0K |
| Repayment of lease liabilities | -$125.0K | -$170.0K | -$444.0K |
| NET CASH PROVIDED BY FINANCING ACTIVITIES | $3.7M | $468.0K | $21.2M |
| Effects of exchange rate changes on cash and cash equivalents | -$15.0K | $2.0K | |
| NET (DECREASE) IN CASH AND CASH EQUIVALENTS | -$6.5M | -$22.3M | -$619.0K |
| Restricted share awards vested | $68.0K | ||
| Accrued transaction costs | $280.0K | ||
| Conversion of pre-closing Apollomics convertible preferred shares into Post-Closing Apollomics Ordinary Shares | $588.3M | ||
| Initial value of warrant liabilities arising from Maxpro note conversion and PIPE Financing in connection with the Closing Date of the Business Combination | $629.0K | ||
| Reclassification from equity to non-current liabilities for Maxpro Warrants assumed by Apollomics upon Closing | $1.3M | ||
| Reconciliation of movements in Right of use assets / Lease liability | $142.0K | $792.0K | |
| Shares issued to employees for compensation | $1.5M | ||
| Cashless exercise of warrants | $7.0K |
Recent filings
- Sep 24, 20264/A
- Sep 24, 20264/A
- Sep 24, 20264/A
- Sep 17, 20264
- Sep 17, 20264
- Sep 17, 20264
- Sep 17, 20264
- Sep 17, 20264
- Sep 17, 20264
- Sep 17, 20264
- Sep 8, 2026424B3
- Aug 24, 20264
- Aug 19, 2026D
- Aug 17, 2026SCHEDULE 13D/A
- Aug 17, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARApollomics Inc. filings on SEC EDGAR
- 2Yahoo FinanceAPLM quote
- 3SEC EDGARApollomics Inc. filings on SEC EDGAR
- 4SEC EDGARApollomics Inc. 10-K for fiscal 2024
- 5SEC EDGARApollomics Inc. 10-K for fiscal 2020
- 6SEC EDGARApollomics Inc. 10-K for fiscal 2021
- 7